Open-Label Two-Dose Pilot Study of Landiolol for the Treatment of Atrial Fibrillation/Atrial Flutter in Caucasian Patients

201912 citationsJournal Articlediamond Open Access

Authors

Guenter Stix · Medical University of Vienna

Michael Wolzt · Medical University of Vienna

Hans Domanovits · Medical University of Vienna

Pavla Kadlecová

Bernhard Husch

Michaela Trebs · AOP Orphan (Austria)

Juri Hodisch · AOP Orphan (Austria)

Martin Unger ·

Abstract

Continuous infusion of landiolol with a starting dose of 40 µg/kg/min is suitable for the acute treatment of tachycardic AF/AFL in Caucasian patients. Administration of a preceding bolus seems unnecessary.

Topics & Keywords

Atrial Fibrillation Management and Outcomes Cardiac electrophysiology and arrhythmias Cardiac Arrhythmias and Treatments

Publication Details

Published in: Circulation Journal

Volume 84, Issue 1, pp. 33-42

DOI: 10.1253/circj.cj-19-0661

Field-Weighted Citation Impact: 0.64

Command Palette

Open-Label Two-Dose Pilot Study of Landiolol for the Treatment of Atrial Fibrillation/Atrial Flutter in Caucasian Patients

Authors

Abstract

Topics & Keywords

Publication Details